Contents

Search

multicenter automatic defibrillator implantation trial (MADIT)

Indications: - implantable cardiac defibrillators may improve survival in a selected patient population* at high risk for sudden death. * Selection criteria: - myocardial infarction - left ventricular ejection fraction < 35% - non-sustained ventricular tachycardia - electrophysiologically-induced sustained monomorphic ventricular tachycardia not suppressed by procainamide

Related

implantable cardioverter defibrillator (ICD)

General

clinical trial

References

  1. Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 67
  2. Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998
  3. Journal Watch 21(24):197, 2001 Sanders et al, Ann Intern Med 135:870, 2001